As of 2025-06-17, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 13.7x | 13.3x |
| Forward P/E multiples | 13.0x - 18.3x | 16.8x |
| Fair Price | (9.75) - (10.01) | (10.48) |
| Upside | -164.0% - -165.7% | -168.7% |
| Date | EV/EBITDA |